Orc integrates with Cscreen to provide OTC pricing and reporting
25 April 2012 | 1212 views | 0
Orc, a leading provider of technology and services for the global financial industry, today announced that it has integrated the Orc Trading products with Cscreen, NYSE Liffe's global pre-trade price discovery platform, providing traders with a more efficient way of interfacing Indications of Interests (IOIs) for equity and index derivatives from inter-dealer brokers (IDBs).
The Cscreen integration provides Orc users with an efficient way to bring together their activities in the OTC equity derivatives markets alongside their on-screen trading. Leveraging Orc's rich functionality in strategy trading, the Cscreen solution enables traders to quickly price and assess any incoming IOIs for swift trading decisions. Traders can now benefit from an aggregated, comprehensive view of total trading risk in both listed and OTC markets.
"The integration with Cscreen is a natural extension of our electronic trading solutions allowing firms to more efficiently manage their OTC trading flows," said Jon Freebody, VP Sales at Orc. "As markets and regulations evolve, providing a tighter integration between OTC trading and electronic trading will allow firms to continue to grow their businesses."
"This exciting new initiative brings together two leading service providers," said Jason Lee, Head of Cscreen, NYSE Liffe. "Having more accurate information available in a more concise and aggregated view will give our customers the added benefit of a clearer and more informed platform on which to make trading decisions."